Buddy Wilson - Grown Rogue VP Sales

GRUSF Stock  USD 0.70  0.01  1.41%   

Insider

Buddy Wilson is VP Sales of Grown Rogue International
Phone458 226 2100
Webhttps://www.grownrogue.com

Grown Rogue Management Efficiency

The company has return on total asset (ROA) of 0.1475 % which means that it generated a profit of $0.1475 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2575 %, meaning that it generated $0.2575 on every $100 dollars invested by stockholders. Grown Rogue's management efficiency ratios could be used to measure how well Grown Rogue manages its routine affairs as well as how well it operates its assets and liabilities.
Grown Rogue International has accumulated 1.37 M in total debt with debt to equity ratio (D/E) of 0.53, which is about average as compared to similar companies. Grown Rogue International has a current ratio of 1.58, which is within standard range for the sector. Debt can assist Grown Rogue until it has trouble settling it off, either with new capital or with free cash flow. So, Grown Rogue's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Grown Rogue International sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Grown to invest in growth at high rates of return. When we think about Grown Rogue's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Richard MDCollegium Pharmaceutical
64
Mark BaldygaBiofrontera
N/A
Hermann LubbertBiofrontera
68
Kevin MacDermottcbdMD Inc
62
Marlo ManningCollegium Pharmaceutical
N/A
Muthusamy RPhANI Pharmaceuticals
56
Rami LevyINC Research Holdings
59
BComm BComAkanda Corp
68
Advocate OhayonINC Research Holdings
35
David EricksonEvolus Inc
N/A
CCFP DipSportMedEvolus Inc
60
Scott SudduthCollegium Pharmaceutical
N/A
Raymond CoffmancbdMD Inc
62
Tejinder VirkAkanda Corp
42
BCom BAccAkanda Corp
44
Jeff HolmBiofrontera
N/A
Eugene IIIBiofrontera
39
Alex DasallaCollegium Pharmaceutical
N/A
Elizabeth JDANI Pharmaceuticals
N/A
Thomas FlowAkanda Corp
46
Amos CohenINC Research Holdings
45
Grown Rogue International Inc., through its subsidiaries, engages in growing and selling cannabis products in the United States. Grown Rogue International Inc. is headquartered in Medford, Oregon. Grown Rogue operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. Grown Rogue International [GRUSF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Grown Rogue International Leadership Team

Elected by the shareholders, the Grown Rogue's board of directors comprises two types of representatives: Grown Rogue inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Grown. The board's role is to monitor Grown Rogue's management team and ensure that shareholders' interests are well served. Grown Rogue's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Grown Rogue's outside directors are responsible for providing unbiased perspectives on the board's policies.
Buddy Wilson, VP Sales
Steven Lightman, Special CEO
Adam August, VP LLC
Obie Strickler, CEO Pres
Ryan Kee, Chief CFO

Grown Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Grown Rogue a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Grown OTC Stock

Grown Rogue financial ratios help investors to determine whether Grown OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Grown with respect to the benefits of owning Grown Rogue security.